POLLY

Katarina Topalov, Arndt Schimmelmann, P. David Polly and Peter E. Sauer... 

Topalov, K., Schimmelmann, A., Polly, P.D., Sauer, P.E., Lowiy, M. (2009). D/H of bone collagen as environmental and trophic indicator. Goldschmidt Conference Abstracts 2009, Davos, Switzerland (http //goldschmidt.info/2009/abstracts/T.pdf)... 

Polli JW, Jarrett JL, Studenberg SD, Humphreys JE, Dennis SW, Brouwer KR, et al. Role of P-glycoprotein on the CNS disposition of amprenavir (141W94), an HIV protease inhibitor. Pharm Res 1999 16 1206-12. 

E. Capito, L. Bernardi, M. Comes-Franchini, F. Fini, M. Fochi, S. Polli-cino and A. Ricci, Tetrahedron Asymmetry, 2005, 16, 3232-3240. 

All piroxicam batches were manufactured in compliance with Good Manufacturing Practices, and three formulations having fast, moderate, and slow dissolution were chosen for comparison to a lot of the innovator s product in a human bioavailability study [100]. The resulting pharmacokinetic data provided still another opportunity to examine the effects of formulation variables. To explore the relationship between the in vitro dissolution of piroxicam from these capsules and in vivo absorption, Polli [ 102] used the following previously described [145] deconvolution-based model ... 

KB Shah, LL Augsburger, LE Small, GP Polli. Instrumentation of a dosing disc automatic capsule filling machine. Pharm Tech 7(4) 42-54, 1983. 

JE Polli. Analysis of in vitro - in vivo data. In GL Amidon, JR Robinson, RL Williams, eds. Scientific Foundations for Regulating Drug Products. Arlington, VA AAPS Press, 1997, pp 335-351. 

JE Polli, JR Crison, GL Amidon. Novel approach to the analysis of an in vitro-in vivo relationships. J Pharm Sci 85 753-760, 1996. 

N. A. Williams, Y. Lee, G. P. Polli, and T. A. Jennings, The effects of cooling rate on solid phase transitions and associated vial breakage occurring in frozen mannitol solutions, J. Parenter. Sci. Technol., 40,135-141 (1986). 

Lentz, K. A. Hayashi, J. Lucisano, L. J. Polli, J. E., Development of a more rapid, reduced serum culture system for Caco-2 monolayers and application to the biopharmaceutics classification system, Int. J. Pharm. 200, 41-51 (2000). 

Polly Hill. Telephone interview, May 6, 2000. Source for Moore wrapping Carothers around finger Hohman telling Carothers to marry and agnosticism. 

Williams, Jr, John W., Cynthia D. Mulrow, Elaine Chiquette, Polly Hitchcock Noel, Christine Aguilar and John Cornell, A Systematic Review of Newer Pharmacotherapies for Depression in Adults Evidence Report Summary , Annals of Internal Medicine 132 (2000) 743-56... 

GP Polli, CE Shoop, WM Grim. Controlled release medicinal tablets. US Patent... 

M. Mahar Doan Kelly, E. Humphreys Joan, O. Webster Lindsey, A. Wring Stephen, J. Shampine Larry, J. Serabjit-Singh Cosette, K. Adkison Kimberly, and W. Polli Joseph, / Pharmacol Exp Ther, 2002, 303,1029. 

Physics Department Moscow State University 119992 Moscow, Russia khokhlov polly.phys.msu.ru... 

Harold Kung Kathleen Taylor Gary Haller Polly Burwell Haynes Lou Allred... 

Ricci MS, De Almeida DL, Ribeiro RD, Aquino AM, Pereira JC, Polli D, Reis VM, Eklund CR (2000) Cyperus rotundus control by solarization. Biol Agric Hort 17 151-157 Rieger M, Krewer G, Lewis P (2001) Solarization and chemical alternatives to methyl bromide for preplant soil treatment of strawberries. HortTechnology 11 258-264 Ristaino JB, Perry KB, Lumsden RD (1991) Effect of soil solarization and Gliocladium virens on sclerotia of Sclerotium rolfsii, soil microbiota, and the incidence of southern blight in tomato. Phytopathology 81 1117-1124... 

Rautio, J., Humphreys, J.E., Webster, L. O., Balakrishnan, A., Keogh, J.P., Kunta, J.R., Serabjit-Singh, C.J. and Polli, J.W. (2006) In vitro P-glycoprotein inhibition assays for assessment of clinical drug interaction potential of new drug candidates a recommendation for probe substrates. Drug Metabolism and Disposition, 34, 786-792. 

Gombar, V.K., Polli, J.W., Humphreys, J.E., Wring, S.A. and Serabjit-Singh, C. S. (2004) Predicting P-glycoprotein substrates by a quantitative structure-activity relationship model, fournal... 

In a series of papers (23-26), Polli and colleagues proposed alternative direct curve comparison metrics on this level. In their papers, attention was focused on two aspects (i) are means or medians more suitable for comparison and (ii) how can symmetric confidence intervals be constructed that are invariant when exchanging reference and test In addition, this work was devoted to bioavailability and bioequivalence, i.e., time profiles in vivo, but the conclusions apply likewise to in vitro-release profiles. 

Marston and Polli (24) compared the performance of the Rescigno index , and the Moore-Flanner index /) with a metric originally proposed by Chinchilli and Elswick (27). The latter is defined in terms of lower and upper boundaries of the test region = min[T,CR/T)it J and 7 j = max[T,CR/... 

T)i ]. Polli and McLean (26) defined and compared four additional metrics, in which the denominator is 2(R+T), and which are symmetric about R and T ... 

---